Authors
Gábor Cserni, Róbert Maráz, László Venczel, Gábor Boross, Péter Molnár, Mária Sinkó, Nóra Szeleczki, Éva Ambrózay, Orsolya Serfőző, Gabriella Gábor, Dóra Tigyi, Judit Kocsis, Zsolt Horváth, Rita Bori
Published in
Magyar onkologia. Volume 70. Issue 3. Pages 227-237. Sep 11, 2026. Epub May 16, 2026.
Abstract
We introduced sentinel lymph node biopsy for breast cancer in 1997. Axillary lymphadenectomy was performed routinely at the beginning, then limited to sentinel node positive cases, macrometastatic cases and ultimately, to >2 nodes or post-neoadjuvant metastatic cases. From vital blue dye only labelling, (combined) radiocolloid, fluorescent and radar localisation labelling all received their place in the staging procedure. Histopathology also changed: 1. from extensive analysis identifying as many small metastases as possible to identifying/excluding macrometastatic involvement, 2. from routine to restricted use of immunohistochemistry, 3. from routine imprint cytology identifying as many macrometastases as possible to its selective use. The review describes these changes and also points to the rationale behind them. Along practical considerations, surgical and pathological techniques may undergo further changes in the future.
PMID:
42731001
Bibliographic data and abstract were imported from PubMed on 13 Sep 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0